Overview A Safety and Tolerability Study of FCN-207 in Healthy Volunteers Status: Recruiting Trial end date: 2022-06-07 Target enrollment: Participant gender: Summary This research study is studying an investigational drug called FCN-207 in healthy adult males or females. Phase: Phase 1 Details Lead Sponsor: Fochon Pharmaceuticals, Ltd.